Science Corporation announced that the company raised $230 million as it awaits a decision from the Food and Drug Administration on PRIMA, its wireless retinal implant. The Series C funding round includes investors from Lightspeed Venture Partners, Khosla Ventures, Y Combinator, Quiet Capital, and IQT, the investor arm for the CIA and the broader U.S. intelligence community.